Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele D Vos

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Methods in Enzymology|June 8, 2006
RASSF family proteins and Ras transformationMichele D Vos, Geoffrey J Clark
Journal of Cell Science|September 20, 2007
The RASSF1A tumor suppressorHoward Donninger, Michele D Vos, Geoffrey J Clark
The Journal of Biological Chemistry|April 5, 2003
The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lungMichele D Vos, Alfredo Martinez, Chad A Ellis, et al.
Cancer Research|December 3, 2004
RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF familyKristin Eckfeld, Luke Hesson, Michele D Vos, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2002
Rig is a novel Ras-related protein and potential neural tumor suppressorChad A Ellis, Michele D Vos, Heather Howell, et al.
The Journal of Biological Chemistry|May 7, 2003
RASSF2 is a novel K-Ras-specific effector and potential tumor suppressorMichele D Vos, Chad A Ellis, Candice Elam, et al.
Cancer Research|June 19, 2004
A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stabilityMichele D Vos, Alfredo Martinez, Candice Elam, et al.
Cancer Research|May 14, 2009
NORE1A tumor suppressor candidate modulates p21CIP1 via p53Diego F Calvisi, Howard Donninger, Michele D Vos, et al.
The Journal of Cell Biology|March 18, 2015
NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2Howard Donninger, Diego F Calvisi, Thibaut Barnoud, et al.
Breast Cancer Research and Treatment|March 4, 2003
Tamoxifen and the farnesyl transferase inhibitor FTI-277 synergize to inhibit growth in estrogen receptor-positive breast tumor cell linesChad A Ellis, Michele D Vos, Meredith Wickline, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Methods in Enzymology|June 8, 2006
RASSF family proteins and Ras transformationMichele D Vos, Geoffrey J Clark
Journal of Cell Science|September 20, 2007
The RASSF1A tumor suppressorHoward Donninger, Michele D Vos, Geoffrey J Clark
The Journal of Biological Chemistry|April 5, 2003
The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lungMichele D Vos, Alfredo Martinez, Chad A Ellis, et al.
Cancer Research|December 3, 2004
RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF familyKristin Eckfeld, Luke Hesson, Michele D Vos, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2002
Rig is a novel Ras-related protein and potential neural tumor suppressorChad A Ellis, Michele D Vos, Heather Howell, et al.
The Journal of Biological Chemistry|May 7, 2003
RASSF2 is a novel K-Ras-specific effector and potential tumor suppressorMichele D Vos, Chad A Ellis, Candice Elam, et al.
Cancer Research|June 19, 2004
A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stabilityMichele D Vos, Alfredo Martinez, Candice Elam, et al.
Cancer Research|May 14, 2009
NORE1A tumor suppressor candidate modulates p21CIP1 via p53Diego F Calvisi, Howard Donninger, Michele D Vos, et al.
The Journal of Cell Biology|March 18, 2015
NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2Howard Donninger, Diego F Calvisi, Thibaut Barnoud, et al.
Breast Cancer Research and Treatment|March 4, 2003
Tamoxifen and the farnesyl transferase inhibitor FTI-277 synergize to inhibit growth in estrogen receptor-positive breast tumor cell linesChad A Ellis, Michele D Vos, Meredith Wickline, et al.
Pageof 2